CSF1R blockade with PLX647, instead, depleted suppressive MDSCs and reduced the tumor promoting activity of M2 macrophages, delaying tumor growth only in the B16-IDO melanoma model, but not in control B16. Here, CSF1R is linked to neoplasm.